42 results on '"Becker, Daniel Jacob"'
Search Results
2. Retrospective review of compliance with guideline-directed germline testing in microsatellite instability-high colorectal cancer treated at the Veterans Health Administration.
3. Analysis of the impact of eliminating bolus 5-fluorouracil in metastatic colorectal cancer.
4. Effect of incorporating NGS ordering into computerized patient records system (CPRS) on VA precision oncology care.
5. Experiences of researchers fulfilling VHA’s “fourth mission” during the COVID-19 pandemic.
6. Clinical and demographical factors associated with fertility counseling in colorectal cancer.
7. Association of socioeconomic status and molecular testing in stage IV colorectal cancer.
8. Fertility counseling in young patients with colorectal cancer.
9. Exploring the Cancer Genome Atlas (TCGA) for the molecular profile of young onset colorectal cancers.
10. A phase I/II multisite study of nivolumab and carboplatin/paclitaxel with radiation therapy (RT) in patients with locally advanced esophageal squamous cell carcinoma (ESCC).
11. A phase II, randomized, controlled trial of nivolumab in combination with BMS-986253 or cabiralizumab in advanced hepatocellular carcinoma (HCC) patients.
12. Characterization of a novel entity of high-grade well-differentiated colorectal neuroendocrine tumors.
13. Chronic myeloid leukemia among veterans from 2006-2015: Trends in utilization of tyrosine kinase inhibitors.
14. Patterns of care and outcomes for glioblastoma in patients with poor performance status.
15. Use of molecular testing and EGFR targeted medications for colorectal cancer at VA Hospitals.
16. Association of diabetes with colorectal cancer treatment and outcomes.
17. Use of abiraterone and enzalutamide beyond PSA progression in metastatic prostate cancer.
18. Impact of socioeconomic status on anal cancer survival.
19. RAS mutation testing and cetuximab use for colorectal cancer at VA Hospitals.
20. Equity in access to tyrosine kinase inhibitors among veterans diagnosed with renal cell carcinoma.
21. Association of diabetes with colorectal cancer treatment and outcomes.
22. Cardiotoxicity of tyrosine kinase inhibitors among veterans diagnosed with renal cell carcinoma.
23. Contribution of polypharmacy and potentially inappropriate medication use to inferior survival in older patients with aggressive lymphoma.
24. Exploration of the ASCO and ESMO value frameworks for cancer drugs.
25. Adverse impact of polypharmacy and potentially inappropriate medication use in newly diagnosed, elderly lymphoma patients.
26. Influence of geographic mobility on lung cancer survival.
27. Qualitative analysis of barriers to precision oncology within the VHA.
28. Phase II study of lenvatinib plus pembrolizumab for patients with immunotherapy-naive advanced gastric cancer following first line therapy.
29. Real-world rates of FDA-approved targeted therapy and immunotherapy prescriptions for patients with metastatic colorectal cancer in the VA's National Precision Oncology Program (NPOP).
30. Influence of extent of lymphadenectomy on survival for localized non-small cell lung cancer.
31. Metformin with a carbohydrate-restricted diet in combination with platinum-based chemotherapy in advanced-stage lung adenocarcinoma.
32. Utility of surveillance imaging in patients with non-Hodgkin lymphoma.
33. Cancer trends among the extreme elderly in the era of cancer screening.
34. Survival benefit of Asian females in the era of targeted therapy for advanced lung cancer.
35. Can racial and financial disparities be overcome in the surgical treatment of NSCLC?
36. Impact of leucovorin shortage on patient treatment.
37. Uptake and disparities of neoadjuvant therapy for stage III non-small cell lung cancer.
38. HIV-associated lung cancer in New York City.
39. Uptake of recommendations for adequate nodal removal in colorectal cancer resection.
40. KRAS mutations and outcomes for patients with stage IV NSCLC treated with frontline platinum/pemetrexed based chemotherapy.
41. Impact of oncology drug shortages on patient treatment.
42. Contribution of polypharmacy and potentially inappropriate medication use to inferior survival in older patients with aggressive lymphoma.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.